194 related articles for article (PubMed ID: 7585778)
1. Platelets and platelet inhibitors in acute myocardial infarction.
Kamat SG; Kleiman NS
Cardiol Clin; 1995 Aug; 13(3):435-47. PubMed ID: 7585778
[TBL] [Abstract][Full Text] [Related]
2. The role of platelets and platelet inhibition in acute myocardial infarction.
Valettas N; Herrmann HC
Coron Artery Dis; 2003 Aug; 14(5):357-63. PubMed ID: 12878900
[No Abstract] [Full Text] [Related]
3. IIb/IIIa inhibitors in acute myocardial infarction.
Montalescot G
Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S71-5. PubMed ID: 10070824
[TBL] [Abstract][Full Text] [Related]
4. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
Vyshlov EV; Panfilova EV; Markov VA
Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombotic agents in acute myocardial infarction].
Boschat J; Larlet JM; Gilard M
Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():19-26. PubMed ID: 9749272
[TBL] [Abstract][Full Text] [Related]
6. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
7. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Xiao Z; Théroux P
J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
Becker RC
Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769
[TBL] [Abstract][Full Text] [Related]
10. Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction.
Ghosh K; Khare A; Shetty S; Nair S; Kulkarni B; Mohanty D
Natl Med J India; 2006; 19(2):73-4. PubMed ID: 16756193
[TBL] [Abstract][Full Text] [Related]
11. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
12. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
13. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
[TBL] [Abstract][Full Text] [Related]
14. [Effects of thrombolysis on platelets and coagulation].
Helft G; Abdelouahed M; Vacheron A; Lecompte T; Samama MM
Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):354-60. PubMed ID: 8561440
[TBL] [Abstract][Full Text] [Related]
15. Platelet factor 4 as a marker of platelet activation in patients with acute myocardial infarction.
Dymicka-Piekarska V; Kemona H; Mantur M; Stogowski A; Kemona-Chetnik I; Bychowski J
Rocz Akad Med Bialymst; 2000; 45():96-103. PubMed ID: 11712446
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
Eccleston D; Topol EJ
Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
[No Abstract] [Full Text] [Related]
17. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
[TBL] [Abstract][Full Text] [Related]
18. Take an aspirin or have a drink: antecedent aspirin and moderate alcohol consumption similarly affect baseline platelet characteristics in patients with acute myocardial infarction.
Serebruany VL; Lowry DR;
Thromb Haemost; 2000 Nov; 84(5):933-4. PubMed ID: 11127889
[No Abstract] [Full Text] [Related]
19. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
